title: Cell-Free Hepatitis B Virus Capsid Assembly Dependent on the Core Protein C-Terminal Domain and Regulated by Phosphorylation.
abstract: Multiple subunits of the hepatitis B virus (HBV) core protein (HBc) assemble into an icosahedral capsid that packages the viral pregenomic RNA (pgRNA). The N-terminal domain (NTD) of HBc is sufficient for capsid assembly, in the absence of pgRNA or any other viral or host factors, under conditions of high HBc and/or salt concentrations. The C-terminal domain (CTD) is deemed dispensable for capsid assembly although it is essential for pgRNA packaging. We report here that HBc expressed in a mammalian cell lysate, rabbit reticulocyte lysate (RRL), was able to assemble into capsids when (low-nanomolar) HBc concentrations mimicked those achieved under conditions of viral replication in vivo and were far below those used previously for capsid assembly in vitro Furthermore, at physiologically low HBc concentrations in RRL, the NTD was insufficient for capsid assembly and the CTD was also required. The CTD likely facilitated assembly under these conditions via RNA binding and protein-protein interactions. Moreover, the CTD underwent phosphorylation and dephosphorylation events in RRL similar to those seen in vivo which regulated capsid assembly. Importantly, the NTD alone also failed to accumulate in mammalian cells, likely resulting from its failure to assemble efficiently. Coexpression of the full-length HBc rescued NTD assembly in RRL as well as NTD expression and assembly in mammalian cells, resulting in the formation of mosaic capsids containing both full-length HBc and the NTD. These results have important implications for HBV assembly during replication and provide a facile cell-free system to study capsid assembly under physiologically relevant conditions, including its modulation by host factors.
  
  
  
  Hepatitis B virus (HBV) is an important global human pathogen and the main cause of liver cancer worldwide. An essential component of HBV is the spherical capsid composed of multiple copies of a single protein, the core protein (HBc). We have developed a mammalian cell-free system in which HBc is expressed at physiological (low) concentrations and assembles into capsids under near-physiological conditions. In this cell-free system, as in mammalian cells, capsid assembly depends on the C-terminal domain (CTD) of HBc, in contrast to other assembly systems in which HBc assembles into capsids independently of the CTD under conditions of nonphysiological protein and salt concentrations. Furthermore, the phosphorylation state of the CTD regulates capsid assembly and RNA encapsidation in the cell-free system in a manner similar to that seen in mammalian cells. This system will facilitate detailed studies on capsid assembly and RNA encapsidation under physiological conditions and identification of antiviral agents that target HBc.
authors.affiliation: Department of Microbiology and Immunology, Penn State University College of Medicine, Hershey, Pennsylvania, USA.
authors.forename: Laurie
authors.initials: L
authors.lastname: Ludgate
authors.affiliation: Department of Microbiology and Immunology, Penn State University College of Medicine, Hershey, Pennsylvania, USA.|College of Life Sciences, Zhejiang Sci-Tech University, Hangzhou, China.
authors.forename: Kuancheng
authors.initials: K
authors.lastname: Liu
authors.affiliation: Department of Microbiology and Immunology, Penn State University College of Medicine, Hershey, Pennsylvania, USA.
authors.forename: Laurie
authors.initials: L
authors.lastname: Luckenbaugh
authors.affiliation: Department of Microbiology and Immunology, Penn State University College of Medicine, Hershey, Pennsylvania, USA.
authors.forename: Nicholas
authors.initials: N
authors.lastname: Streck
authors.affiliation: Gilead Sciences, Foster City, California, USA.
authors.forename: Stacey
authors.initials: S
authors.lastname: Eng
authors.affiliation: Gilead Sciences, Foster City, California, USA.
authors.forename: Christian
authors.initials: C
authors.lastname: Voitenleitner
authors.affiliation: Gilead Sciences, Foster City, California, USA.
authors.forename: William E
authors.initials: WE
authors.lastname: Delaney
authors.affiliation: Department of Microbiology and Immunology, Penn State University College of Medicine, Hershey, Pennsylvania, USA juh13@psu.edu.
authors.forename: Jianming
authors.initials: J
authors.lastname: Hu
mesh_terms: D000818:Animals; D002213:Capsid / Q000737:chemistry / Q000378:metabolism*; D036022:Capsid Proteins / Q000737:chemistry / Q000378:metabolism*; D002474:Cell-Free System; D015967:Gene Expression Regulation, Viral; D006512:Hepatitis B Core Antigens / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism*; D006515:Hepatitis B virus / Q000502:physiology*; D054884:Host-Pathogen Interactions; D006801:Humans; D010766:Phosphorylation; D000072417:Protein Domains; D012367:RNA, Viral / Q000378:metabolism; D011817:Rabbits; D012156:Reticulocytes; D014758:Viral Core Proteins / Q000737:chemistry* / Q000235:genetics; D019065:Virus Assembly; D014779:Virus Replication
chemical_list: D036022:Capsid Proteins; D006512:Hepatitis B Core Antigens; D012367:RNA, Viral; D014758:Viral Core Proteins